Pfizer, Novartis, Merck Executives Say They Are Hunting for Deals Again.
The acquisitions could help the companies add new sales to aging lineups and suggest this year could be a busy one for industry dealmaking.Now that its blockbuster immune-disease therapy Humira is facing lower priced competition, AbbVie is turning to a pair of next-generation successors to replenish the billions of dollars in sales that will be lost.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Health & Pharma News | Latest Healthcare Stories | ReutersAustralia will roll out a fifth dose of COVID vaccine later this month to all citizens aged 18 and above who have not contracted coronavirus or been vaccinated in the past six months, its health minister said. Read more health and pharma news 👉 It's a subscription model. Who's counting shots at this point, and who's counting profits? including spacesThis is a stark reminder that the natural world is complex and interconnected, and that changes in one area can have profound consequences elsewhere. We must be vigilant and take preventative measures to protect human health. BirdFlu GlobalHealth DelthiaRicks
Source: ReutersScience - 🏆 559. / 51 Read more »